Person profile
Public information reviewedG. Clare Kahn, Ph.D.
Board role
Director · Stoke Therapeutics, Inc. (NASDAQ: STOK)
Stoke Therapeutics, Inc. (NASDAQ: STOK)
Director · Current mandate
- Evidence records
- 2
- Profile ownership
- Not yet claimed
- Record reviewed
- Sep 13, 2026

